Re:Non-Indians have benefited most from patent regime in India
by r0h1n on Wednesday August 28, 2013 @01:20PM
(#6291336)
As the OP has mentioned, this is the Indian government's response to Novartis. Here is the background:
1. In April, India's Supreme Court denied Novartis' patent application for its cancer drug Glivec. They reasoned that Novartis was "evergreening" the drug, and thus did not deserve a patent for a new drug - http://articles.economictimes.indiatimes.com/2013-04-02/news...
1. In April, India's Supreme Court denied Novartis' patent application for its cancer drug Glivec. They reasoned that Novartis was "evergreening" the drug, and thus did not deserve a patent for a new drug - http://articles.economictimes.indiatimes.com/2013-04-02/news...
2. Novartis complained, naturally - http://www.novartis.com/newsroom/media-releases/en/2013/1689...
[Edited: a couple of typos]